KDM5B and metastatic melanoma: For instance, in metastatic melanoma, enrichment of JARID1B slow-cycling subpopulation was formed following the treatment with cisplatin and vemurafenib, inhibition of OXPHOS was then resulted in the suspension of JARID1B+ subpopulation formation and making melanoma cells more vulnerable to chemotherapy agents [318] (Table 1).